Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY

Fiona A Pearce; Sean H Lim; Mary Bythell; Peter Lanyon; Rachel Hogg; Adam Taylor; Gillian Powter; Graham S Cooke; Helen Ward; Joseph Chilcot; Helen Thomas; Lisa Mumford; Stephen P McAdoo; Gavin J Pettigrew; Liz Lightstone; Michelle Willicombe

doi:10.1101/2023.02.09.23285649

Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY

View ORCID ProfileFiona A Pearce, Sean H Lim, Mary Bythell, Peter Lanyon, Rachel Hogg, Adam Taylor, Gillian Powter, Graham S Cooke, View ORCID ProfileHelen Ward, Joseph Chilcot, Helen Thomas, Lisa Mumford, Stephen P McAdoo, Gavin J Pettigrew, Liz Lightstone, View ORCID ProfileMichelle Willicombe

doi: https://doi.org/10.1101/2023.02.09.23285649

Fiona A Pearce

1Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK

2Department of Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, UK

3National Disease Registration Service, NHS Digital, Leeds, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Fiona A Pearce

Sean H Lim

4Centre for Cancer Immunology, University of Southampton, Southampton, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mary Bythell

3National Disease Registration Service, NHS Digital, Leeds, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Lanyon

1Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK

2Department of Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, UK

3National Disease Registration Service, NHS Digital, Leeds, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rachel Hogg

5Statistics and Clinical Research, NHS Blood and Transplant, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adam Taylor

1Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK

3National Disease Registration Service, NHS Digital, Leeds, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gillian Powter

6NHS Blood and Transplant Clinical Trials Unit, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Graham S Cooke

7Department of Infectious Disease, Imperial College London, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helen Ward

7Department of Infectious Disease, Imperial College London, London, UK

8School of Public Health, Imperial College London, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Helen Ward

Joseph Chilcot

9Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helen Thomas

5Statistics and Clinical Research, NHS Blood and Transplant, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa Mumford

5Statistics and Clinical Research, NHS Blood and Transplant, Bristol, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephen P McAdoo

10Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London, UK

11Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gavin J Pettigrew

12Department of Surgery, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Liz Lightstone

10Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London, UK

11Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michelle Willicombe

10Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London, UK

11Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michelle Willicombe
For correspondence: m.willicombe08@imperial.ac.uk

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplemental Data[supplements/285649_file05.docx]

View the discussion thread.

PreviousNext

Posted February 14, 2023.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY

Fiona A Pearce, Sean H Lim, Mary Bythell, Peter Lanyon, Rachel Hogg, Adam Taylor, Gillian Powter, Graham S Cooke, Helen Ward, Joseph Chilcot, Helen Thomas, Lisa Mumford, Stephen P McAdoo, Gavin J Pettigrew, Liz Lightstone, Michelle Willicombe

medRxiv 2023.02.09.23285649; doi: https://doi.org/10.1101/2023.02.09.23285649

Share This Article: